Training Initiatives

In 2016, EFNA launched its Training Initiatives for Neurology Advocates [TINA].
For many years EFNA has run workshops on Health Technology Assessment and, lately, Pharmaceutical Policy – Pricing, Access and Reimbursement at the London School of Economics.
However, feedback from participants indicates that patients now need to be equipped to use the theoretical knowledge gained on these processes, and the wider research and development cycle, in a more practical way.
For example, through the development of communication, advocacy and campaigning skills and the generation of patient evidence or patient reported outcomes.

EFNA is also eager to ensure that our training activities are targeted to the neurology sector and the specific obstacles faced therein. Working with other stakeholders in the field e.g. neuroscientists, neurologists, industry, regulators and payers is part of our envisaged way forward.

Under TINA, EFNA plans to run at least three workshops annually for neurology patient advocates at both a pan-European and National level.

Get in touch if you are interested in:

Suggesting your country as a location for a national workshop and supporting us locally
Suggesting a topic for an upcoming workshop
Participating in an upcoming event
Coming on board as a sponsor
Any other aspect of the initiative

NEWS:

An EFNA-commissioned report into neurology patient engagement in Health Technology Assessment has shown uncertainty in how the provision of a patient perspective impacts final decisions.
The report concluded that further research involving patients and other stakeholders is needed to gain a better understanding of patient groups or patients with neurological disorders can improve the HTA decision-making process.
Read more here

UPCOMING EVENTS

Dates of upcoming events will be posted here shortly

COMPLETED EVENTS

PAN-EUROPEAN

Brussels, December 3 – 4, 2019

Neuroscience Research & Development: Influencing, Engaging and Optimizing Opportunities for Patient Involvement

Warsaw, October 28 – 29, 2019

Advocating for Access to neurology treatment, services and supports

—————————–

Brussels, March 7 – 8, 2019

Linking Global, European and National Policy Priorities

—————————–

Brussels, November 19-20, 2018

Patient Advocacy in the Digital World –
A workshop for young advocates

Please note that spaces for this workshop have been filled.

Read the event report
Download presentations here

—————————–

Bucharest, October 15-16, 2018

The Future of Healthcare in the EU:
Towards more sustainable healthcare organisations

Read the event report
Download presentations here

—————————–

Berlin, July 6-7, 2018:

Science for Advocates
Read the event report
Download presentations here
—————————–

Lisbon, April 17-18, 2018:

Value – Patient Preferences and Perspectives
Read the event report
Download presentations here
—————————–

Brussels, May 2017:

Effective External Ambassadorship
Download presentation here
—————————–

Dublin, October 2016:

Putting the Neurology Patient Perspective at the Heart of Research and Beyond
Focus on Patient Generated Evidence and Patient Relevant Outcomes
Download presentations here

NATIONAL

Bucharest, March 12, 2018:

The brain, cognition and personalized medicine
Read the event report
—————————–

Warsaw, December 1^st 2017:

How to Become Your Own Advocate
Read the event report
Watch a Video Recording (video from 25mins)
Download presentations here
—————————–

Valencia, October 26^th – 27^th 2017:

Understanding and Influencing Healthcare Decision-Making
Focus on: Health Technology Assessment
Find out more
—————————–

Bucharest, July 21^st 2017:

Science, Storytelling and Social Affairs
Read the event report
Download presentations here
—————————–

Utrecht, The Netherlands – November 2016

—————————–

Bucharest, Romania – October 2016

This initiative has been made possible through unrestricted educational grants from the below sponsors, who have had no direct influence over the final agenda – including the selection of topics, speakers, case-studies, etc. The objective of this meeting is to upksill neurology patient advocates to participate in the R&D process and beyond – and the outcomes will be disseminated in an appropriate manner to allow for this objective to be met.

Thanks to Biogen, Merck, Teva, MSD.